Your session is about to expire
← Back to Search
Topical Analgesic
Capsaicin for CHS
Phase 4
Waitlist Available
Led By Angela Holian, PharmD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days (outpatient phone call)
Awards & highlights
Study Summary
This trial will test if capsaicin cream can help people with a condition that causes them to vomit a lot.
Eligible Conditions
- Cannabinoid Hyperemesis Syndrome
- CHS
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days (outpatient phone call)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days (outpatient phone call)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to resolution of symptoms
Secondary outcome measures
Clinical improvement in pain score
Other outcome measures
Symptom improvement at thirty days
Side effects data
From 2018 Phase 4 trial • 80 Patients • NCT0228815631%
nasopharyngitis
19%
Nasal congestion
13%
Cough
13%
Rhinorrhoea
6%
Pyrexia
6%
Cystitis
6%
Rhinitis
6%
Influenza
6%
Sneezing
6%
Laryngitis
6%
pain in extremity
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
0,01mM
0,1mM
0.001mM
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CapsaicinExperimental Treatment1 Intervention
capsaicin 0.075% cream applied once topically
Group II: PlaceboActive Control1 Intervention
placebo cream applied once topically
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Capsaicin
FDA approved
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
759 Previous Clinical Trials
1,245,536 Total Patients Enrolled
Angela Holian, PharmDPrincipal Investigator - University of Virginia
University of Virginia
Share this study with friends
Copy Link
Messenger